Apotex Inc - Company Profile
Powered by 
All the data and insights you need on Apotex Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Apotex Inc Strategy Report
- Understand Apotex Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Apotex Inc (Apotex), a subsidiary of SK Capital Partners LP, develops and manufactures generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and consumer products. It carries out the research, development, manufacture, and distribution of non-prescription and private label medicines, fine chemicals, and disposable plastics for medical use. The company serves patients, healthcare providers and payers, governments, and other pharmaceutical manufacturers. The company operates through subsidiaries, joint ventures and licensing agreements across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Apotex is headquartered in Toronto, Ontario, Canada.
Headquarters
Canada
Address
150 Signet Drive, Toronto, Ontario, M9L1T9
Website
www1.apotex.com
Telephone
1 800 2684623
No of Employees
8,000
Industry
Pharmaceuticals and Healthcare
Apotex Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Generic Pharmaceuticals | Apixaban |
| Non-Prescription Medicines | Apo-Deferasirox |
| Private Label Medicines | Deferasirox (Type J) |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In April, the company signed an agreement to acquire Searchlight Pharma Inc. |
| 2023 | Acquisitions/Mergers/Takeovers | In April, the company was acquired by SK Capital Partners LP. |
| 2023 | Others | In April, the company received a Drug Shortage Assistance Award from the US FDA in recognition of the company’s substantial efforts to resolve a shortage of varenicline tablets. |
Competitor Comparison
| Key Parameters | Apotex Inc | Liminal BioSciences Inc | Duchesnay Inc | Eloxx Pharmaceuticals Inc | Resilience Biotechnologies Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | Canada | Canada | United States of America | United States of America |
| City | Toronto | Belleville | Blainville | Watertown | La Jolla |
| State/Province | Ontario | Ontario | Quebec | Massachusetts | California |
| No. of Employees | 8,000 | 43 | - | 18 | - |
| Entity Type | Private | Private | Private | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Allan Oberman | Chief Executive Officer; President | Senior Management | 2023 | - |
| Peter Hardwick | Executive Vice President; Chief Commercial Officer | Senior Management | 2018 | - |
| Carina Vassilieva | Chief Human Resources Officer | Senior Management | 2023 | - |
| Kevin Zive | Vice President; Head - Global Intellectual Property; General Counsel | Senior Management | - | - |
| Steven Liberty | Executive Vice President - Global Supply and Manufacturing | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward